Herantis Pharma (Finland) Probability of Future Stock Price Finishing Under 0.06
| HRTIS Stock | EUR 1.54 0.08 4.94% |
Herantis |
Herantis Pharma Target Price Odds to finish below 0.06
The tendency of Herantis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 0.06 or more in 90 days |
| 1.54 | 90 days | 0.06 | near 1 |
Based on a normal probability distribution, the odds of Herantis Pharma to drop to € 0.06 or more in 90 days from now is near 1 (This Herantis Pharma Oyj probability density function shows the probability of Herantis Stock to fall within a particular range of prices over 90 days) . Probability of Herantis Pharma Oyj price to stay between € 0.06 and its current price of €1.54 at the end of the 90-day period is more than 93.0 .
Assuming the 90 days trading horizon Herantis Pharma Oyj has a beta of -0.45. This usually indicates as returns on the benchmark increase, returns on holding Herantis Pharma are expected to decrease at a much lower rate. During a bear market, however, Herantis Pharma Oyj is likely to outperform the market. Additionally Herantis Pharma Oyj has an alpha of 0.0573, implying that it can generate a 0.0573 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Herantis Pharma Price Density |
| Price |
Predictive Modules for Herantis Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Herantis Pharma Oyj. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Herantis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Herantis Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Herantis Pharma is not an exception. The market had few large corrections towards the Herantis Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Herantis Pharma Oyj, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Herantis Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -0.45 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.04 |
Herantis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Herantis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Herantis Pharma Oyj can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Herantis Pharma Oyj may become a speculative penny stock | |
| Herantis Pharma Oyj has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K. | |
| Herantis Pharma Oyj has accumulated about 7.86 M in cash with (9.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Roughly 32.0% of the company shares are held by company insiders |
Herantis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Herantis Stock often depends not only on the future outlook of the current and potential Herantis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Herantis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.1 M |
Herantis Pharma Technical Analysis
Herantis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Herantis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Herantis Pharma Oyj. In general, you should focus on analyzing Herantis Stock price patterns and their correlations with different microeconomic environments and drivers.
Herantis Pharma Predictive Forecast Models
Herantis Pharma's time-series forecasting models is one of many Herantis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Herantis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Herantis Pharma Oyj
Checking the ongoing alerts about Herantis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Herantis Pharma Oyj help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Herantis Pharma Oyj may become a speculative penny stock | |
| Herantis Pharma Oyj has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K. | |
| Herantis Pharma Oyj has accumulated about 7.86 M in cash with (9.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Roughly 32.0% of the company shares are held by company insiders |
Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.